MacroGenics Inc - Company Profile
Powered by
All the data and insights you need on MacroGenics Inc in one report.
- Save hours of research time and resources with
our up-to-date MacroGenics Inc Strategy Report
- Understand MacroGenics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
MacroGenics Clinical Trials
Determine MacroGenics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of MacroGenics Clinical Trials data
Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
---|---|---|---|---|---|---|---|
Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION) | GDCT0462104 | lorigerlimab | Oncology | Cervical Cancer; Metastatic Cancer | Phase II | Ongoing, recruiting | University of Texas MD Anderson Cancer Center |
MGC018 Versus Androgen Receptor Axis-targeted Therapy in Participants With Metastatic Castration Resistant Prostate Cancer (Tamarack) | GDCT0456679 | vobramitamab duocarmazine | Oncology | Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer; Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer; Metastatic Prostate Cancer | Phase II/III | Ongoing, recruiting | MacroGenics Inc |
A Study of MGD024 in Patients with Relapsed or Refractory Hematologic Malignancies | GDCT0454845 | MGD-024 | Gastrointestinal; Hematological Disorders; Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); B-Cell Leukemia; Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia); Hairy Cell Leukemia; Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma); Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Hematological Disorders; Relapsed Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Systemic Mastocytosis | Phase I | Ongoing, recruiting | MacroGenics Inc |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer